Chung HT - Search Results

1

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.

Lok AS, Wu PC, Lai CL, Lau JY, Leung EK, Wong LS, Ma OC, Lauder IJ, Ng CP, Chung HT. Lok AS, et al. Among authors: chung ht. Gastroenterology. 1992 Jun;102(6):2091-7. doi: 10.1016/0016-5085(92)90337-x. Gastroenterology. 1992. PMID: 1587429 Clinical Trial.

2

Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases.

Lok AS, Lai CL, Chung HT, Lau JY, Leung EK, Wong LS. Lok AS, et al. Among authors: chung ht. Hepatology. 1991 May;13(5):834-7. doi: 10.1002/hep.1840130506. Hepatology. 1991. PMID: 1709410

3

A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection.

Lau JY, Lai CL, Wu PC, Chung HT, Lok AS, Lin HJ. Lau JY, et al. Among authors: chung ht. J Med Virol. 1991 Jul;34(3):184-7. doi: 10.1002/jmv.1890340310. J Med Virol. 1991. PMID: 1919540 Clinical Trial.

4

Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.

Lai CL, Lin HJ, Lau JN, Flok AS, Wu PC, Chung HT, Wong LK, Leung MP, Yeung CY. Lai CL, et al. Among authors: chung ht. Q J Med. 1991 Feb;78(286):155-63. Q J Med. 1991. PMID: 2031078 Clinical Trial.

5

Synergism of chronic alcoholism and hepatitis B infection in liver disease.

Chung HT, Lai CL, Wu PC, Lok AS. Chung HT, et al. J Gastroenterol Hepatol. 1989 Jan-Feb;4(1):11-6. doi: 10.1111/j.1440-1746.1989.tb00801.x. J Gastroenterol Hepatol. 1989. PMID: 2490936

6

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.

Lai CL, Wu PC, Lok AS, Lin HJ, Ngan H, Lau JY, Chung HT, Ng MM, Yeoh EK, Arnold M. Lai CL, et al. Among authors: chung ht. Br J Cancer. 1989 Dec;60(6):928-33. doi: 10.1038/bjc.1989.392. Br J Cancer. 1989. PMID: 2557881 Free PMC article. Clinical Trial.

7

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.

Lok AS, Chung HT, Liu VW, Ma OC. Lok AS, et al. Among authors: chung ht. Gastroenterology. 1993 Dec;105(6):1833-8. doi: 10.1016/0016-5085(93)91082-s. Gastroenterology. 1993. PMID: 8253359

8

Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial.

Lai CL, Lau JY, Wu PC, Ngan H, Chung HT, Mitchell SJ, Corbett TJ, Chow AW, Lin HJ. Lai CL, et al. Among authors: chung ht. Hepatology. 1993 Mar;17(3):389-94. Hepatology. 1993. PMID: 8383088 Clinical Trial.

9

Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction.

Chung HT, Lok AS, Lai CL. Chung HT, et al. J Hepatol. 1993 Feb;17(2):208-14. doi: 10.1016/s0168-8278(05)80040-6. J Hepatol. 1993. PMID: 8445234 Clinical Trial.

10

Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays.

Lok AS, Kwan WK, Moeckli R, Yarbough PO, Chan RT, Reyes GR, Lai CL, Chung HT, Lai TS. Lok AS, et al. Among authors: chung ht. Lancet. 1992 Nov 14;340(8829):1205-8. doi: 10.1016/0140-6736(92)92901-q. Lancet. 1992. PMID: 1359270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters